Mucormycosis and Role of COVID-19 in its Pathogenicity in India: A Review

Authors

  • Chiradeep Basu School of Environmental Studies, Jadavpur University, Kolkata, West Bengal, India.
  • Subarna Bhattacharyya School of Environmental Studies, Jadavpur University, Kolkata, West Bengal, India.

DOI:

https://doi.org/10.21276/apjhs.2022.4S1.26

Keywords:

Clinical microbiology, Environmental microbiology, Immunology, Infectious disease, Mucormycosis

Abstract

Mucormycosis is a rising cause of invasive fungal infection but difficulty in diagnosis is the biggest detriment to early diagnosis. Rhinocerebral zygomycosis is most prevalent leading to vascular invasion, tissue necrosis, or even death. Rhizopus arrhizus is the most common causative agent of the disease, found on decaying organic matter but disease from Cunninghamella and Rhizomucor species should not be overlooked. The recent outbreak of COVID-19 pandemic has given rise to increasing patients of diabetes mellitus whose post-COVID immunocompromised state coupled with steroid use has led to rising numbers of mucormycosis patients in India. The establishment of a standard for permissible levels of microbial load in indoor environments has been suggested.

Downloads

Download data is not yet available.

Downloads

Published

2022-06-30

How to Cite

Chiradeep Basu, & Subarna Bhattacharyya. (2022). Mucormycosis and Role of COVID-19 in its Pathogenicity in India: A Review. Asian Pacific Journal of Health Sciences, 9(4), 149–155. https://doi.org/10.21276/apjhs.2022.4S1.26

Similar Articles

You may also start an advanced similarity search for this article.